2023 annual financial data
Innate Pharma 2023 Financial results
Direct answer
Revenue was 51,901,000 EUR.
Operating income was -12,669,000 EUR and net income was -7,570,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,901,000 EUR
- Operating income
- -12,669,000 EUR
- Net income
- -7,570,000 EUR
- Operating cash flow
- Not available
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Innate Pharma financial years